A novel nomogram to predict all-cause readmission or death risk in Chinese elderly patients with heart failure

Mengxi Yang1, Liyuan Tao2, Hui An3

  • 1Department of Cardiology, China-Japan Friendship Hospital, Beijing, China.

ESC Heart Failure
|April 23, 2020
PubMed

Insights

This study developed accurate nomograms to predict heart failure readmission or death in elderly Chinese patients. These tools can help reduce readmission and mortality rates in this vulnerable population.

Area of Science:

  • Cardiology
  • Geriatrics
  • Medical Informatics

Background:

  • Elderly patients with heart failure (HF) experience high rates of all-cause readmission and mortality.
  • Accurate prediction models are needed to identify high-risk individuals for targeted interventions.

Purpose of the Study:

  • To develop and validate an accurate and user-friendly model for predicting all-cause readmission or death risk in Chinese elderly patients with HF.
  • To identify key clinical factors associated with short-term (30-day) and long-term (1-year) adverse outcomes.

Main Methods:

  • A prospective cohort study involving 854 elderly patients (≥65 years) with HF.
  • Data collection included demographics, comorbidities, laboratory values, and medications.
  • Cox regression analysis and nomogram development with bootstrap validation were employed to identify predictors and build the model.

Main Results:

  • The 30-day and 1-year cumulative all-cause readmission rates were 10.5% and 34.9%, respectively.
  • The 30-day and 1-year cumulative mortality rates were 11.6% and 19.7%, respectively.
  • Key predictors for both 30-day and 1-year outcomes included older age, stroke, low diastolic blood pressure, low BMI, reduced estimated glomerular filtration rate, and high BNP levels. Specific factors also predicted individual time points.

Conclusions:

  • Accurate and easy-to-use nomograms were developed to predict all-cause readmission or death in Chinese elderly HF patients.
  • These predictive tools can aid clinicians in risk stratification and potentially reduce adverse outcomes.
  • The study highlights the importance of comprehensive assessment in managing elderly HF patients.
Abstract

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
237
Dosage Regimen Designs: Nomograms and Tabulations01:23

Dosage Regimen Designs: Nomograms and Tabulations

Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
110
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
346
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
184
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
116
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.6K